TAMMY TORREY: Open Payments
NPI 1033203724 · LARGO, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,388 in 111 payments from 18 companies in 2025. Trend: 2023 $3,500 · 2024 $3,447 · 2025 $2,388
Food & beverage: $2,388
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 20 | $395 |
| Takeda Pharmaceuticals U.S.A., Inc. | 16 | $306 |
| Janssen Biotech, Inc. | 10 | $239 |
| QOL Medical, LLC | 9 | $224 |
| PFIZER INC. | 10 | $174 |
| Madrigal Pharmaceuticals | 5 | $154 |
| Gilead Sciences, Inc. | 7 | $140 |
| Lilly USA, LLC | 6 | $139 |
| Regeneron Healthcare Solutions, Inc. | 5 | $113 |
| GENZYME CORPORATION | 3 | $92 |
Products named: TREMFYA, ENTYVIO, Sucraid, DUPIXENT, REZDIFFRA, XELJANZ, LINZESS, OMVOH.
Industry payments across FL — which companies pay providers there.
